» Articles » PMID: 31509711

Breaking Symmetry: Engineering Single-Chain Dimeric Streptavidin As Host for Artificial Metalloenzymes

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2019 Sep 12
PMID 31509711
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The biotin-streptavidin technology has been extensively exploited to engineer artificial metalloenzymes (ArMs) that catalyze a dozen different reactions. Despite its versatility, the homotetrameric nature of streptavidin (Sav) and the noncooperative binding of biotinylated cofactors impose two limitations on the genetic optimization of ArMs: (i) point mutations are reflected in all four subunits of Sav, and (ii) the noncooperative binding of biotinylated cofactors to Sav may lead to an erosion in the catalytic performance, depending on the cofactor:biotin-binding site ratio. To address these challenges, we report on our efforts to engineer a (monovalent) single-chain dimeric streptavidin (scdSav) as scaffold for Sav-based ArMs. The versatility of scdSav as host protein is highlighted for the asymmetric transfer hydrogenation of prochiral imines using [Cp*Ir(biot--L)Cl] as cofactor. By capitalizing on a more precise genetic fine-tuning of the biotin-binding vestibule, unrivaled levels of activity and selectivity were achieved for the reduction of challenging prochiral imines. Comparison of the saturation kinetic data and X-ray structures of [Cp*Ir(biot--L)Cl]·scdSav with a structurally related [Cp*Ir(biot--L)Cl]·monovalent scdSav highlights the advantages of the presence of a single biotinylated cofactor precisely localized within the biotin-binding vestibule of the monovalent scdSav. The practicality of scdSav-based ArMs was illustrated for the reduction of the salsolidine precursor (500 mM) to afford ()-salsolidine in 90% ee and >17 000 TONs. Monovalent scdSav thus provides a versatile scaffold to evolve more efficient ArMs for in vivo catalysis and large-scale applications.

Citing Articles

Rational design of allosteric switchable catalysts.

Pan T, Wang Y, Xue X, Zhang C Exploration (Beijing). 2023; 2(2):20210095.

PMID: 37323883 PMC: 10191014. DOI: 10.1002/EXP.20210095.


Unified access to up-to-date residue-level annotations from UniProtKB and other biological databases for PDB data.

Choudhary P, Anyango S, Berrisford J, Tolchard J, Varadi M, Velankar S Sci Data. 2023; 10(1):204.

PMID: 37045837 PMC: 10097656. DOI: 10.1038/s41597-023-02101-6.


Spiers Memorial Lecture: Shielding the active site: a streptavidin superoxide-dismutase chimera as a host protein for asymmetric transfer hydrogenation.

Igareta N, Tachibana R, Spiess D, Peterson R, Ward T Faraday Discuss. 2023; 244(0):9-20.

PMID: 36924204 PMC: 10416703. DOI: 10.1039/d3fd00034f.


Dynamic Ir(III) Photosensors for the Major Human Drug-Metabolizing Enzyme Cytochrome P450 3A4.

Denison M, Ahrens J, Dunbar M, Warmahaye H, Majeed A, Turro C Inorg Chem. 2023; 62(7):3305-3320.

PMID: 36758158 PMC: 10268476. DOI: 10.1021/acs.inorgchem.3c00059.


Ir(III)-Based Agents for Monitoring the Cytochrome P450 3A4 Active Site Occupancy.

Denison M, Steinke S, Majeed A, Turro C, Kocarek T, Sevrioukova I Inorg Chem. 2022; 61(35):13673-13677.

PMID: 35994607 PMC: 9547529. DOI: 10.1021/acs.inorgchem.2c02587.


References
1.
Heinisch T, Ward T . Artificial Metalloenzymes Based on the Biotin-Streptavidin Technology: Challenges and Opportunities. Acc Chem Res. 2016; 49(9):1711-21. DOI: 10.1021/acs.accounts.6b00235. View

2.
Reznik G, Vajda S, Sano T, Cantor C . A streptavidin mutant with altered ligand-binding specificity. Proc Natl Acad Sci U S A. 1998; 95(23):13525-30. PMC: 24852. DOI: 10.1073/pnas.95.23.13525. View

3.
Hyster T, Knorr L, Ward T, Rovis T . Biotinylated Rh(III) complexes in engineered streptavidin for accelerated asymmetric C-H activation. Science. 2012; 338(6106):500-3. PMC: 3820005. DOI: 10.1126/science.1226132. View

4.
Reetz M, Peyralans J, Maichele A, Fu Y, Maywald M . Directed evolution of hybrid enzymes: Evolving enantioselectivity of an achiral Rh-complex anchored to a protein. Chem Commun (Camb). 2006; (41):4318-20. DOI: 10.1039/b610461d. View

5.
Mallin H, Hestericova M, Reuter R, Ward T . Library design and screening protocol for artificial metalloenzymes based on the biotin-streptavidin technology. Nat Protoc. 2016; 11(5):835-52. DOI: 10.1038/nprot.2016.019. View